Pharma Mar | PHM - Assets


Pharma Mar reported EUR341.66M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Alaunos Therapeutics USD 3.72M 1.01M Sep/2025
Almirall EUR 2.31B 88.74M Jun/2025
Avita Medical AUD 58.13M 21.58M Jun/2025
Dianthus Therapeutics USD 577.44M 251.37M Sep/2025
Ionis Pharmaceuticals USD 3.03B 47.96M Sep/2025
IQVIA Holdings USD 28.73B 95M Sep/2025
Laboratorios Farma EUR 799.88M 99.95M Dec/2023
Moderna USD 12.14B 125M Sep/2025
Organon & Co USD 13.55B 52M Sep/2025
Pharma Mar EUR 341.66M 6.59M Sep/2025
Revvity USD 12.14B 223.84M Sep/2025
Tectonic Therapeutic USD 277M 18.31M Sep/2025
Viatris USD 37.92B 491.1M Sep/2025
Xeris Pharmaceuticals USD 370.19M 35.5M Sep/2025